The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines
Open accessAbstract
Background: Several multi-attribute utility instruments (MAUIs) are available from which utilities can be derived for use in cost-utility analysis (CUA). This study provides a review of recommendations from national health technology assessment (HTA) agencies regarding the choice of MAUIs. Methods: A list was compiled of HTA agencies that provide or refer to published official pharmacoeconomic (PE) guidelines for pricing, reimbursement or market access. The guidelines were reviewed for recommendations on the indirect calculation of utilities and categorized as: a preference for a specific MAUI; providing no MAUI preference, but providing examples of suitable MAUIs and/or recommending the use of national value sets; and recommending CUA, but not providing examples of MAUIs. Results: Thirty-four PE guidelines were included for review. MAUIs named for use in CUA: EQ-5D (n = 29 guidelines), the SF-6D (n = 11), HUI (n = 10), QWB (n = 3), AQoL (n = 2), CHU9D (n = 1). EQ-5D was a preferred MAUI in 15 guidelines. Alongside the EQ-5D, the HUI was a preferred MAUI in one guideline, with DALY disability weights mentioned in another. Fourteen guidelines expressed no preference for a specific MAUI, but provided examples: EQ-5D (n = 14), SF-6D (n = 11), HUI (n = 9), QWB (n = 3), AQoL (n = 2), CHU9D (n = 1). Of those that did not specify a particular MAUI, 12 preferred calculating utilities using national preference weights. Conclusions: The EQ-5D, HUI, and SF-6D were the three MAUIs most frequently mentioned in guidelines. The most commonly cited MAUI (in 85% of PE guidelines) was EQ-5D, either as a preferred MAUI or as an example of a suitable MAUI for use in CUA in HTA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EQ-5D and the EuroQol group: past, present and future
Devlin, N. J., & Brooks, R. (2017) · Applied Health Economics and Health Policy · doi:10.1007/s40258-017-0310-5 · Cited by 1,189
The EQ-5D-5L Valuation study in Thailand
Pattanaphesaj, J., Thavorncharoensap, M., Ramos-Goñi, J. M., Tongsiri, S., Ingsrisawang, L., & Teerawattananon, Y. (2018) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2018.1494574 · Cited by 205
International Regulations and Recommendations for Utility Data for Health Technology Assessment
Rowen, D., Azzabi Zouraq, I., Chevrou-Severac, H., & van Hout, B. (2017) · PharmacoEconomics · doi:10.1007/s40273-017-0544-y · Cited by 161
EQ-5D in Central and Eastern Europe: 2000–2015
Rencz, F., Gulàcsi, L., Drummond, M., Golicki, D., Rupel, V. P., Simon, J., Stolk, E. A., Brodszky, V., Baji, P., Závada, J., et al. (2016) · Quality of Life Research · doi:10.1007/s11136-016-1375-6 · Cited by 157
Richardson, J. R. J., Iezzi, A., & Khan, M. A. (2015) · Quality of Life Research · doi:10.1007/s11136-015-0926-6 · Cited by 108
Multiattribute Utility Instruments and Their Use
Richardson, J. R. J., Mckie, J. R., & Bariola, E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-375678-7.00505-8 · Cited by 107
HTA Implementation Roadmap in Central and Eastern European Countries
Kaló, Z., Gheorghe, A., Huić, M., Csanádi, M., & Kristensen, F. B. (2016) · Health Economics · doi:10.1002/hec.3298 · Cited by 76
A systematic review of pharmacoeconomic guidelines
Zhao, Y., Feng, H., Ji, Q., Luo, X., Ma, W., & Tian, J. (2017) · Journal of Medical Economics · doi:10.1080/13696998.2017.1387118 · Cited by 56
Bae, S., Lee, S.-O., Bae, E. Y., & Jang, S. (2013) · PharmacoEconomics · doi:10.1007/s40273-012-0021-6 · Cited by 50
The Future of Health Technology Assessment in Healthcare Decision Making in Asia
Yang, B. (2009) · PharmacoEconomics · doi:10.2165/11310280-000000000-00000 · Cited by 40
Cited by
Methods for Analysing and Reporting EQ-5D Data
Devlin, N., Parkin, D., & Janssen, B. (2020) · Springer eBooks · doi:10.1007/978-3-030-47622-9 · Cited by 371
Metadata
- Authors
- Kennedy-Martin, M., Slaap, B., Herdman, M., van Reenen, M., Kennedy-Martin, T., Greiner, W., Busschbach, J., & Boye, K. S.
- Venue
- The European Journal of Health Economics
- Published
- 2020-06-08
- Volume
- 21
- Issue
- 8
- Pages
- 1245-1257
- ISSN
- 1439-3972 (ISSN-L)
- 1618-7598
- 1618-7601
- OpenAlex
- W3033327429
- Cited by
- 304
- References
- 10
- FWCI
- 30.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. https://app.cochat.ai/papers/10.1007/s10198-020-01195-8
- The paper
- Kennedy-Martin, M., Slaap, B., Herdman, M., van Reenen, M., Kennedy-Martin, T., Greiner, W., Busschbach, J., & Boye, K. S. (2020). Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. The European Journal of Health Economics. https://doi.org/10.1007/s10198-020-01195-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.